While the only known curative treatment for LAM is lung transplantation, mTOR pathway inhibitors like sirolimus are the mainstay of management for patients with LAM, along with supportive therapy such as bronchodilators, supplemental oxygen, and pulmonary rehabilitation [10]. The gene discussed is MTOR; the disease is lymphangioleiomyomatosis.